Caliway Biopharmaceuticals Co Ltd

NEW
TPE:6919 (Taiwan)  
NT$ 99.6 -3.4 (-3.3%) Aug 28
At Loss
P/B:
16.84
Market Cap:
NT$ 155.01B ($ 4.89B)
Enterprise V:
NT$ 151.07B ($ 4.77B)
Volume:
10.67M
Avg Vol (2M):
5.80M
Trade In:
Volume:
10.67M
At Loss
Avg Vol (2M):
5.80M

Caliway Biopharmaceuticals Co Ltd (TPE:6919) Dividend

Caliway Biopharmaceuticals Co Ltd (TPE:6919) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -36.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: TPE:6919 Dividend

Does Caliway Biopharmaceuticals Co Ltd (TPE:6919) pay a dividend?

Caliway Biopharmaceuticals Co Ltd (TPE:6919) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Caliway Biopharmaceuticals Co Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Caliway Biopharmaceuticals Co Ltd has returned capital to shareholders via buybacks at a rate of -36.1% over the past 3 years.

What are dividend-paying alternatives to Caliway Biopharmaceuticals Co Ltd?

For dividend-paying alternatives in Caliway Biopharmaceuticals Co Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.